Clinical Trial Update: sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. [NA]

View source ↗

Summary

A clinical trial evaluating whether planned delivery guided by the sFlt1/PlGF biomarker ratio can prevent preeclampsia at term.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction
• Maternal Hypertension
• Preeclampsia

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Preeclampsia, Intrauterine Growth Restriction | NA | Status: RECRUITING